Christopherr Cline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Christopherr cline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Christopherr Cline Today - Breaking & Trending Today

Brokerages Set Travere Therapeutics, Inc. (NASDAQ:TVTX) Target Price at $17.85

Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the fifteen analysts that are presently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average […] ....

Peter Heerma , Piper Sandler , Christopherr Cline , Zurcher Kantonalbank Zurich Cantonalbank , Wells Fargo Company , Dynamic Technology Lab Private Ltd , Nisa Investment Advisors , Securities Exchange Commission , Travere Therapeutics Company Profile , China Universal Asset Management Co , Travere Therapeutics Inc , Travere Therapeutics , Get Free Report , Exchange Commission , Investment Advisors , Universal Asset Management , Technology Lab Private Ltd , Kantonalbank Zurich Cantonalbank , Get Free , Iga Nephropathy , Travere Therapeutics Daily ,

Travere Therapeutics, Inc. (NASDAQ:TVTX) Receives $17.85 Average Target Price from Brokerages

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the fifteen ratings firms that are covering the company, MarketBeat.com reports. Six analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 1-year price objective among […] ....

Christopherr Cline , Zurcher Kantonalbank Zurich Cantonalbank , Piper Sandler , Travere Therapeutics Company Profile , Cheyne Capital Management United Kingdom , Emerald Mutual Fund Advisers , Sg Americas Securities , Emerald Advisers , Wells Fargo Company , Travere Therapeutics Inc , Travere Therapeutics , Get Free Report , Kantonalbank Zurich Cantonalbank , Mutual Fund Advisers Trust , Get Free , Iga Nephropathy , Travere Therapeutics Daily , Nasdaq Tvtx ,

Travere Therapeutics, Inc. Expected to Earn FY2025 Earnings of ($1.80) Per Share (NASDAQ:TVTX)

Travere Therapeutics, Inc. Expected to Earn FY2025 Earnings of ($1.80) Per Share (NASDAQ:TVTX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Christopherr Cline , Piper Sandler , Peter Heerma , Vanguard Group Inc , Jacobs Levy Equity Management Inc , Armistice Capital , Wells Fargo Company , Travere Therapeutics Inc , Travere Therapeutics , Free Report , Travere Therapeutic , Get Free Report , Wells Fargo , Capital Management , Levy Equity Management , Finepoint Capital , Iga Nephropathy , Travere Therapeutics Daily ,

HC Wainwright Boosts Travere Therapeutics (NASDAQ:TVTX) Price Target to $19.00

Travere Therapeutics (NASDAQ:TVTX – Get Free Report) had its price target lifted by HC Wainwright from $17.00 to $19.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s target price indicates a potential upside of 248.62% from the company’s […] ....

United States , Piper Sandler , Peter Heerma , Christopherr Cline , Rice Hall James Associates , Wells Fargo Company , Mirae Asset Global Investments Co , Travere Therapeutics Company Profile , Travere Therapeutics Inc , Securities Exchange Commission , Travere Therapeutics , Get Free Report , Therapeutics Stock Down , Exchange Commission , Retirement System , State Retirement System , Asset Global Investments , Rice Hall James , Hall James , Iga Nephropathy , Travere Therapeutics Daily , Nasdaq Tvtx , Boost Price Target , Hc Wainwright ,

HC Wainwright Increases Travere Therapeutics (NASDAQ:TVTX) Price Target to $19.00

Travere Therapeutics (NASDAQ:TVTX – Get Free Report) had its target price hoisted by equities research analysts at HC Wainwright from $17.00 to $19.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 248.62% from the stock’s […] ....

Christopherr Cline , Piper Sandler , Schonfeld Strategic Advisors , Travere Therapeutics Inc , Jacobs Levy Equity Management Inc , Securities Exchange Commission , Sg Americas Securities , Wells Fargo Company , Vanguard Group Inc , Travere Therapeutics Company Profile , Jump Financial , Travere Therapeutics , Get Free Report , Therapeutics Stock Down , Exchange Commission , Strategic Advisors , Levy Equity Management , Iga Nephropathy , Travere Therapeutics Daily , Nasdaq Tvtx , Boost Price Target , Hc Wainwright ,